Cialis
Cialis Erectile Dysfunction
Home Bookmark this Site
News » April 2006

Cialis Is Effective In The Treatment Of Men With Erectile Dysfunction Regardless Of Previous Effective Viagra Use
April 25, 2006

The phosphodiesterase type 5 (PDE-5) inhibitors have revolutionized the pharmacologic management of erectile dysfunction (ED). Viagra (sildenafil citrate) was the first of the class to be introduced in 1998 and later followed by Levitra (Vardenafil) and Cialis (Tadalafil) in 2003. Therefore, men currently taking Cialis may have had previous experience with Viagra. Because of the unique properties of each drug, many patients will try more than one of these agents.

Dr. Broderick of the Mayo clinic in Jacksonville, Florida and colleagues recently reviewed 14 placebo controlled, double-blinded trials of Cialis use in men who were either previous Viagra responders or naïve to the PDE-5 class of medications. A total of almost 2800 men were analyzed for this study. Patients who failed to have an erectile response to Viagra were excluded from this analysis.

The investigators found that Cialis at 10 or 20 mg improved erectile function over placebo regardless of previous Viagra use or PDE-5 inhibitor naive patients. Conclusions were based on results measured by the International Index of Erectile Function (IIEF) EF domain score, Sexual Encounter Profile (SEP) questions Q2 (successful penetration) and Q3 (successful intercourse) and a Global Assessment Question (GAQ1) about erectile improvement.

Source: http://www.medicalnewstoday.com/medicalnews.php?newsid=42135&nfid=rssfeeds

News Archive
 Year 2007
 August    
 July    
 June  
 May  
 April  
 March  
 February  
 January  
 Year 2006
 December  
 November  
 October  
 September  
 August  
 July  
 June  
 May  
 April  
 March  
 February  
 January  
 YEAR 2005  
 YEAR 2004  
 YEAR 2003  
 Cialis  

 

 

 

 

 

 

 

Cialis | Erectile Dysfunction | Mens Health Articles | Glossary
© 2006 cpotent.com All Right Reserved
Cialis is a registered trademark of Lilly ICOS LLC. All other trademarks are the property of their respective owners.